Concepedia

Sanjeev Redkar

SR

18

Publications

1.5K

Citations

16

H-Index

2007

Active since

Affiliations

SuperGen (United States)(Current)

Astex Pharmaceuticals

University of Southern California

The University of Texas MD Anderson Cancer Center

University of Auckland

Sanjeev Redkar is an author at SuperGen (United States) specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

2007–2018

18

Publications

18

RETRACTED: A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation

Jharna Datta, Kalpana Ghoshal, William A. Denny et al. · Cancer Research · 2009 · 262 citations · Full text

Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides

Christine B. Yoo, Shinwu Jeong, Gerda Egger et al. · Cancer Research · 2007 · 213 citations · Full text

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

Lisa S. Chen, Sanjeev Redkar, David J. Bearss et al. · Blood · 2009 · 198 citations · Full text

Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia

Lisa S. Chen, Sanjeev Redkar, Pietro Taverna et al. · Blood · 2011 · 160 citations · Full text

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge et al. · Molecular Cancer Therapeutics · 2009 · 152 citations · Full text

, , +12

Rows per page

1–5 of 18